These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17218937)
1. A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. Kosaka S; Akilov OE; O'Riordan K; Hasan T J Invest Dermatol; 2007 Jun; 127(6):1546-9. PubMed ID: 17218937 [No Abstract] [Full Text] [Related]
2. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Akilov OE; Kosaka S; O'Riordan K; Hasan T Exp Dermatol; 2007 Aug; 16(8):651-60. PubMed ID: 17620092 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy as a new treatment of cutaneous leishmaniasis. Ghaffarifar F; Jorjani O; Mirshams M; Miranbaygi MH; Hosseini ZK East Mediterr Health J; 2006 Nov; 12(6):902-8. PubMed ID: 17333838 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Akilov OE; Kosaka S; O'Riordan K; Hasan T Photochem Photobiol Sci; 2007 Oct; 6(10):1067-75. PubMed ID: 17914480 [TBL] [Abstract][Full Text] [Related]
6. Effective treatment with photodynamic therapy of cutaneous leishmaniasis: A case report. Johansen MB; Jemec GBE; Fabricius S Dermatol Ther; 2019 Sep; 32(5):e13022. PubMed ID: 31306550 [TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous leishmaniasis with photodynamic therapy. Enk CD; Fritsch C; Jonas F; Nasereddin A; Ingber A; Jaffe CL; Ruzicka T Arch Dermatol; 2003 Apr; 139(4):432-4. PubMed ID: 12707088 [No Abstract] [Full Text] [Related]
8. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957 [TBL] [Abstract][Full Text] [Related]
9. Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP. Latorre-Esteves E; Akilov OE; Rai P; Beverley SM; Hasan T J Biophotonics; 2010 Jun; 3(5-6):328-35. PubMed ID: 20376860 [TBL] [Abstract][Full Text] [Related]
10. [Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality]. Gardlo K; Hanneken S; Ruzicka T; Neumann NJ Hautarzt; 2004 Apr; 55(4):381-3. PubMed ID: 15021933 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of photodynamic therapy in cutaneous leishmaniasis: a "hidden" local heat effect? Kluger N; Girard C; Debu A; Guillot B Med Hypotheses; 2010 Dec; 75(6):674-5. PubMed ID: 20673703 [No Abstract] [Full Text] [Related]
12. Leishmania tropica successfully treated with photodynamic therapy. Slape DR; Kim EN; Weller P; Gupta M Australas J Dermatol; 2019 Feb; 60(1):e64-e65. PubMed ID: 29932205 [No Abstract] [Full Text] [Related]
13. Photodynamic therapy of cationic and anionic BSA-curcumin nanoparticles on amastigotes of Leishmania braziliensis and Leishmania major and Leishmania amazonensis. Marcolino LMC; Ambrosio JA; Pinto JG; Ferreira I; Simioni AR; Ferreira-Strixino J Photodiagnosis Photodyn Ther; 2024 Apr; 46():104001. PubMed ID: 38342387 [TBL] [Abstract][Full Text] [Related]
14. Re: Efficacy of photodynamic therapy in cutaneous leishmaniasis: A systematic review. Din SZU; Ahmed K; Rengasamy KR; Gul N; Ahmad I Photodiagnosis Photodyn Ther; 2024 Feb; 45():103957. PubMed ID: 38161038 [No Abstract] [Full Text] [Related]
15. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis. Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813 [TBL] [Abstract][Full Text] [Related]
16. Liposomal zinc phthalocyanine as a potential agent for photodynamic therapy of leishmaniasis. Sazgarnia A; Bahreyni-Toosi MH; Layegh P; Rajabi O; Ghodsinia RM Indian J Dermatol Venereol Leprol; 2010; 76(4):417-8. PubMed ID: 20657130 [No Abstract] [Full Text] [Related]
17. In vitro evaluation of photodynamic therapy using curcumin on Leishmania major and Leishmania braziliensis. Pinto JG; Fontana LC; de Oliveira MA; Kurachi C; Raniero LJ; Ferreira-Strixino J Lasers Med Sci; 2016 Jul; 31(5):883-90. PubMed ID: 27056699 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of facial cutaneous leishmaniasis with photodynamic therapy. Alamon-Reig F; Martí-Martí I; Loughlin CR; Garcia A; Carrera C; Aguilera-Peiró P Indian J Dermatol Venereol Leprol; 2022; 88(5):667-670. PubMed ID: 35962517 [No Abstract] [Full Text] [Related]
19. [Successful treatment of cutaneous leishmaniasis with simulated daylight photodynamic therapy]. Hobelsberger S; Krauß MP; Bogdan C; Aschoff R Hautarzt; 2022 May; 73(5):376-378. PubMed ID: 34213573 [TBL] [Abstract][Full Text] [Related]
20. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice. Jabini R; Jaafari MR; Vahdati Hasani F; Ghazizadeh F; Khamesipour A; Karimi G Drug Res (Stuttg); 2015 Mar; 65(3):119-24. PubMed ID: 24623031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]